Showing results (1911-1920 of 1,946) with videos related to

Sort By:
Pageof 195
Nature Genetics|March 22, 2006
Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitisColin N A Palmer, Alan D Irvine, Ana Terron-Kwiatkowski, et al.
Trends in Ecology & Evolution|December 3, 2025
A horizon scan of biological conservation issues for 2026William J Sutherland, Stuart H M Butchart, Stewart J Clarke, et al.
Bioorganic & Medicinal Chemistry|December 2, 2019
Preparation and biological evaluation of BACE1 inhibitors: Leveraging trans-cyclopropyl moieties as ligand efficient conformational constraintsLeonard L Winneroski, Jon A Erickson, Steven J Green, et al.
Communications Biology|June 4, 2021
Comparative analysis of 1152 African-American and European-American men with prostate cancer identifies distinct genomic and immunological differencesWalter Rayford, Alp Tuna Beksac, Jordan Alger, et al.
Journal of Medicinal Chemistry|June 3, 2021
Discovery and Early Clinical Development of LY3202626, a Low-Dose, CNS-Penetrant BACE InhibitorDavid L McKinzie, Leonard L Winneroski, Steven J Green, et al.
The Science of the Total Environment|March 25, 2023
Offshore decommissioning horizon scan: Research priorities to support decision-making activities for oil and gas infrastructureSarah M Watson, Dianne L McLean, Brian J Balcom, et al.
Science Advances|June 7, 2023
A structured jet explains the extreme GRB 221009ABrendan O'Connor, Eleonora Troja, Geoffrey Ryan, et al.
Medrxiv : the Preprint Server for Health Sciences|April 3, 2026
Blood-based RNA-Seq of 5412 individuals with rare disease identifies new candidate diagnoses in the National Genomic Research LibraryJenny Lord, Alistair T Pagnamenta, Letizia Vestito, et al.
Journal of Crohn'S & Colitis|February 16, 2019
Real-world Effectiveness and Safety of Vedolizumab for the Treatment of Inflammatory Bowel Disease: The Scottish Vedolizumab CohortN Plevris, C S Chuah, R M Allen, et al.
EMBO Molecular Medicine|April 4, 2023
Pathological variants in TOP3A cause distinct disorders of mitochondrial and nuclear genome stabilityDirenis Erdinc, Alejandro Rodríguez-Luis, Mahmoud R Fassad, et al.
Pageof 195